Firebrick Pharma Ltd | ABN 64 157 765 896 | L14, 333 Collins St. Melbourne, VIC, 3000, Australia P: 1300 301 874 | W: firebrickpharma.com 7 October 2026 ASX Announcement Firebrick Investor Update Presentation • Investor presentation with important details on the Company’s recently...
Firebrick Investor Update Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Firebrick Pharma Limited on 6ix
In the deck
Story so far
Earlier from Firebrick Pharma
- Firebrick announces USA Retail Launch Plan
- Firebrick receives $293,000 R&D Tax Incentive
- Notice of AGM and Closing Date for Director Nominations
- Appendix 4E and Annual Report 30 June 2026
- Appendix 4G
Later from Firebrick Pharma
- Firebrick Secures $732k in Strategic Investments
- Proposed issue of securities - FRE
- Notice of AGM & Proxy Form & Letter to Shareholders
- Nasodine Nasal Spray Approved in the Philippines
- Application for quotation of securities - FRE
Follow Firebrick Pharma into a list and get an email when it puts out news.
Follow Firebrick Pharma